Regulation of hepatic ABCC transporters by xenobiotics and in disease states
暂无分享,去创建一个
[1] Q. Wang,et al. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. , 1998, Cancer research.
[2] M. Piquette-Miller,et al. Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. , 2000, Molecular cell biology research communications : MCBRC.
[3] A. Harris,et al. The CFTR gene and regulation of its expression , 2005, Pediatric pulmonology.
[4] Y. Iwamoto,et al. Interleukin‐1β represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells , 2004, Hepatology.
[5] K. Zatloukal,et al. Hepatobiliary Transporter Expression in Intercellular Adhesion Molecule 1 Knockout and Fas Receptor-Deficient Mice after Common Bile Duct Ligation Is Independent of the Degree of Inflammation and Oxidative Stress , 2007, Drug Metabolism and Disposition.
[6] P. Jansen,et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats , 2018 .
[7] Y. Sugiyama,et al. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. , 1998, Molecular pharmacology.
[8] N. Bradbury,et al. Endocytic trafficking of CFTR in health and disease. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[9] K. Hirata,et al. Functional expression of organic anion transporters in hepatic organoids reconstructed by rat small hepatocytes , 2008, Journal of cellular biochemistry.
[10] K. Zatloukal,et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.
[11] Kuniharu Nakai,et al. Phospholipid Alterations in Hepatocyte Membranes and Transporter Protein Changes in Cholestatic Rat Model , 2001, Digestive Diseases and Sciences.
[12] Z. Yao,et al. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. , 2008, Cancer letters.
[13] C. Klaassen,et al. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[14] G. Scheffer,et al. Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[15] C. Klaassen,et al. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[16] R. Mancinelli,et al. Morphological and Functional Heterogeneity of the Mouse Intrahepatic Biliary Epithelium , 2008, Laboratory Investigation.
[17] M. Dean,et al. Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. , 2004, Genomics.
[18] Jatinder Lamba,et al. Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450* , 2001, The Journal of Biological Chemistry.
[19] D. Roden,et al. Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variants. , 1999, Biochimica et biophysica acta.
[20] D. Besselsen,et al. Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[21] D. Mangelsdorf,et al. Interleukin-1β Suppresses Retinoid Transactivation of Two Hepatic Transporter Genes Involved in Bile Formation* , 2000, The Journal of Biological Chemistry.
[22] R. Semba,et al. Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.
[23] I. Hyodo,et al. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[24] Y. Sugiyama,et al. Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. , 1999, Biochemical and biophysical research communications.
[25] C. Klaassen,et al. Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. , 2008, Toxicology and applied pharmacology.
[26] S. Oparil,et al. Role of oxygen availability in CFTR expression and function. , 2008, American journal of respiratory cell and molecular biology.
[27] N. LaRusso,et al. Cholangiocyte bile salt transporters in cholesterol gallstone–susceptible and resistant inbred mouse strains , 2008, Journal of gastroenterology and hepatology.
[28] J. Uitto,et al. Tissue-specific expression of the ABCC6 gene. , 2005, The Journal of investigative dermatology.
[29] X. Chu,et al. Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) , 2006, Journal of Pharmacology and Experimental Therapeutics.
[30] K. Sugimachi,et al. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. , 2001, Journal of hepatology.
[31] A. Tordai,et al. Identification of a DNA Methylation-dependent Activator Sequence in the Pseudoxanthoma Elasticum Gene, ABCC6* , 2005, Journal of Biological Chemistry.
[32] S. Kitanaka,et al. Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1β and HNF-1α and the abnormality of HNF-1β mutants , 2007 .
[33] V. Catania,et al. ETHYNYLESTRADIOL INCREASES EXPRESSION AND ACTIVITY OF RAT LIVER MRP3 , 2006, Drug Metabolism and Disposition.
[34] P. Meier,et al. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes , 2001, Hepatology.
[35] P. Borst,et al. Multidrug resistance-associated proteins 3, 4, and 5 , 2007, Pflügers Archiv - European Journal of Physiology.
[36] Jingde Zhu,et al. Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma. , 2004, World journal of gastroenterology.
[37] D. Schrenk,et al. Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites. , 2001, Toxicology.
[38] F. Chou,et al. Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract , 2006, Archives of Toxicology.
[39] D. Keppler,et al. The apical conjugate efflux pump ABCC2 (MRP2) , 2007, Pflügers Archiv - European Journal of Physiology.
[40] Y. Iwamoto,et al. Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes , 2001, The Journal of Biological Chemistry.
[41] A. Ikari,et al. Expression of Hepatic UDP-Glucuronosyltransferase 1A1 and 1A6 Correlated with Increased Expression of the Nuclear Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor α in Male Rats Fed a High-Fat and High-Sucrose Diets⃞ , 2008, Drug Metabolism and Disposition.
[42] Rosalinde Masereeuw,et al. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. , 2008, Trends in pharmacological sciences.
[43] Masaki Kobayashi,et al. Alteration of Mrp2 and P-gp expression, including expression in remote organs, after intestinal ischemia-reperfusion. , 2008, Life sciences.
[44] K. Zatloukal,et al. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. , 2003, Journal of hepatology.
[45] Y. Sugiyama,et al. Characterization of inducible nature of MRP3 in rat liver. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[46] F. Lammert,et al. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. , 2002, Journal of hepatology.
[47] Q. Zhu,et al. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. , 1994, Cancer research.
[48] Gerd A. Kullak-Ublick,et al. Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.
[49] D. Schrenk,et al. Up-regulation of transporters of the MRP family by drugs and toxins. , 2001, Toxicology letters.
[50] C. Klaassen,et al. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice. , 2009, Toxicology and applied pharmacology.
[51] H. Friess,et al. Gender‐specific expression of liver organic anion transporters in rat , 2005, European journal of clinical investigation.
[52] O. Fardel,et al. Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes. , 2000, Biochemical pharmacology.
[53] E. Elias,et al. Coordinated defence and the liver. , 2007, Clinical medicine.
[54] Olivier Fardel,et al. Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.
[55] T. Horie,et al. Oxidative stress and Mrp2 internalization. , 2006, Free radical biology & medicine.
[56] Ariel D. Quiroga,et al. Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity , 2007, Archives of Toxicology.
[57] T. Uchida,et al. Comparative analysis of ATP‐binding cassette (ABC) transporter gene expression levels in peripheral blood leukocytes and in liver with hepatocellular carcinoma , 2004, Cancer science.
[58] A. Gerbes,et al. Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat. , 2005, Journal of hepatology.
[59] C. Kneuer,et al. Endogenous expression of liver-specific drug transporters for organic anions in the rat hepatocytoma fusion cell line HPCT-1E3. , 2005, European journal of cell biology.
[60] Charles Elkan,et al. The Transporter Classification Database: recent advances , 2008, Nucleic Acids Res..
[61] K. Chayama,et al. Unique reciprocal changes of hepatocellular membrane transporter expression and fluidity in rats with selective biliary obstruction. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.
[62] A. Parkinson,et al. Regulation of drug transporter gene expression by nuclear receptors. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[63] K. Brouwer,et al. Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[64] C. Gartung,et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis , 2003, Hepatology.
[65] J. Boyer,et al. Cellular localization and up‐regulation of multidrug resistance–associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver , 2001, Hepatology.
[66] S. Stamm,et al. Expression and chromosome localization of the murine cystic fibrosis transmembrane conductance regulator. , 1992, Genomics.
[67] O. Fardel,et al. Up‐regulation of multidrug resistance‐associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone , 1999, FEBS letters.
[68] T. Ishikawa,et al. MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[69] K. Zatloukal,et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice , 2005, Hepatology.
[70] Y. Kanai,et al. Posttranslational regulation of Abcc2 expression by SUMOylation system. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[71] S. Hirano,et al. Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[72] C. Sinal,et al. Vitamin D Receptor-dependent Regulation of Colon Multidrug Resistance-associated Protein 3 Gene Expression by Bile Acids* , 2005, Journal of Biological Chemistry.
[73] P. Meier,et al. Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin , 2001, Hepatology.
[74] O. Le Saux,et al. [The molecular genetics of pseudoxanthoma elasticum]. , 2001, Annales de dermatologie et de venereologie.
[75] M. Saier,et al. The Transporter Classification (TC) System, 2002 , 2002, Critical reviews in biochemistry and molecular biology.
[76] O. Fardel,et al. Unaltered expression of multidrug resistance transporters in polycyclic aromatic hydrocarbon-resistant rat liver cells. , 2001, Toxicology.
[77] Peijin Zhang,et al. MODULATION OF HEPATIC CANALICULAR OR BASOLATERAL TRANSPORT PROTEINS ALTERS HEPATOBILIARY DISPOSITION OF A MODEL ORGANIC ANION IN THE ISOLATED PERFUSED RAT LIVER , 2005, Drug Metabolism and Disposition.
[78] H. Seguchi,et al. Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[79] J. Marin,et al. Expression, localization, and inducibility by bile acids of hepatobiliary transporters in the new polarized rat hepatic cell lines, Can 3−1 and Can 10 , 2007, Cell and Tissue Research.
[80] J. Manautou,et al. Influence of Acetaminophen Vehicle on Regulation of Transporter Gene Expression During Hepatotoxicity , 2007, Journal of toxicology and environmental health. Part A.
[81] G. Kruh,et al. © 1999 Cancer Research Campaign Article no. bjoc.1999.0527 MOAT-E (ARA) is a full-length MRP/cMOAT subfamily , 2022 .
[82] J. Manautou,et al. Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[83] Y. Lai,et al. Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human , 2009, Drug Metabolism and Disposition.
[84] J. Boyer,et al. Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. , 2002, Gastroenterology.
[85] D. Keppler,et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. , 2003, Journal of hepatology.
[86] F. Baas,et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.
[87] T. Okada,et al. Ethanol consumption alters expression and colocalization of bile salt export pump and multidrug resistance protein 2 in the rat , 2007, Histochemistry and Cell Biology.
[88] J. Marin,et al. Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification. , 2007, Toxicology.
[89] Y. Sugiyama,et al. Characterization of 5'-flanking region of human MRP3. , 2000, Biochemical and biophysical research communications.
[90] M. Wortham,et al. Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver , 2007, Drug Metabolism and Disposition.
[91] Y. Sugiyama,et al. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .
[92] S. Kliewer,et al. Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity* , 2003, Journal of Biological Chemistry.
[93] Xingguo Cheng,et al. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. , 2006, Biochemical pharmacology.
[94] K. Kohno,et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. , 1996, Cancer research.
[95] A. Hutchinson,et al. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. , 2001, Gene.
[96] D. Häussinger,et al. Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. , 2000, The Biochemical journal.
[97] R. Evans,et al. Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice* , 2004, Journal of Biological Chemistry.
[98] K. Zatloukal,et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases , 2001, Hepatology.
[99] S. Narimatsu,et al. Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes. , 2008, Biological & pharmaceutical bulletin.
[100] C. Klaassen,et al. Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. , 2004, Biochemical and biophysical research communications.
[101] P. Meier,et al. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. , 1999, Gastroenterology.
[102] M. Vore,et al. Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition , 2002, Journal of Pharmacology and Experimental Therapeutics.
[103] R. Béliveau,et al. Dexamethasone modulation of multidrug transporters in normal tissues , 1999, FEBS letters.
[104] J. Uitto,et al. Targeted ablation of Abcc1 or Abcc3 in Abcc6−/− mice does not modify the ectopic mineralization process , 2007, Experimental dermatology.
[105] D. Häussinger,et al. Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS , 2004, Biological chemistry.
[106] J. Boyer,et al. Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.
[107] J. Marin,et al. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. , 2006, Life sciences.
[108] J. Cohn,et al. Regulation of membrane chloride currents in rat bile duct epithelial cells. , 1993, The Journal of clinical investigation.
[109] K. Chayama,et al. A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion. , 2005, Journal of atherosclerosis and thrombosis.
[110] R. Béliveau,et al. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. , 1999, American journal of physiology. Renal physiology.
[111] Zhe-Sheng Chen,et al. ABCC10, ABCC11, and ABCC12 , 2007, Pflügers Archiv - European Journal of Physiology.
[112] E. Stange,et al. Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice. , 2002, The Biochemical journal.
[113] Rachel J. Johnson,et al. Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[114] N. Iizuka,et al. Methylation of multiple genes as molecular markers for diagnosis of a small, well‐differentiated hepatocellular carcinoma , 2009, International journal of cancer.
[115] M. Wills. Effects of renal failure. , 1990, Clinical biochemistry.
[116] Olivier Fardel,et al. Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6 , 2009, Drug Metabolism and Disposition.
[117] W. V. D. Van de Ven,et al. The human pseudoxanthoma elasticum gene ABCC6 is transcriptionally regulated by PLAG family transcription factors , 2008, Human Genetics.
[118] M. Kaito,et al. Increased hepatic and renal expressions of multidrug resistance‐associated protein 3 in Eisai hyperbilirubinuria rats , 2004, Journal of gastroenterology and hepatology.
[119] D. Keppler,et al. Up‐regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver , 2001, Hepatology.
[120] C. Klaassen,et al. Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats , 2008, Drug Metabolism and Disposition.
[121] M. Karin,et al. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. , 2007, Drug metabolism and disposition: the biological fate of chemicals.
[122] T. Ishikawa,et al. Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. , 2007, Journal of experimental therapeutics & oncology.
[123] Peijin Zhang,et al. CHARACTERIZATION OF TRANSPORT PROTEIN EXPRESSION IN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) 2-DEFICIENT RATS , 2006, Drug Metabolism and Disposition.
[124] William Saurin,et al. Getting In or Out: Early Segregation Between Importers and Exporters in the Evolution of ATP-Binding Cassette (ABC) Transporters , 1999, Journal of Molecular Evolution.
[125] D. Schrenk,et al. Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. , 2001, Toxicology.
[126] Xingguo Cheng,et al. TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE , 2005, Drug Metabolism and Disposition.
[127] J. Ostrow,et al. Upregulation in the expression of multidrug resistance protein Mrp1 mRNA and protein by increased bilirubin production in rat. , 2003, Biochemical and biophysical research communications.
[128] David T Szabo,et al. Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[129] D. Häussinger,et al. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. , 1999, Gastroenterology.
[130] J. Boyer,et al. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. , 2004, Journal of hepatology.
[131] D. Keppler,et al. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAJ) gene in liver , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[132] W. Duan,et al. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. , 2008, Current medicinal chemistry.
[133] Y. Sugiyama,et al. Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices. , 2008, Biological & pharmaceutical bulletin.
[134] S. Tsuchida,et al. Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats1 , 2004, Transplantation.
[135] P. Bosma,et al. Zonal down‐regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver , 2000, Hepatology.
[136] Micheline Piquette-Miller,et al. The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.
[137] G. F. Sullivan,et al. Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells. , 2000, The Journal of clinical investigation.
[138] J. Boyer,et al. HEPATIC AND EXTRAHEPATIC SYNTHESIS AND DISPOSITION OF DINITROPHENYL-S-GLUTATHIONE IN BILE DUCT-LIGATED RATS , 2006, Drug Metabolism and Disposition.
[139] T. Cantz,et al. Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF‐B , 1998, Hepatology.
[140] V. Douet,et al. DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. , 2007, Biochemical and biophysical research communications.
[141] C. Carlberg,et al. The vitamin D receptor. , 2007, Dermatologic clinics.
[142] Jeffrey S Moffit,et al. Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α , 2006, Journal of Pharmacology and Experimental Therapeutics.
[143] K. Faber,et al. ATP binding cassette transporter gene expression in rat liver progenitor cells , 2003, Gut.
[144] K. Ushinohama,et al. Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats , 2006, Cancer science.
[145] D. Keppler,et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.
[146] M. Gyamfi,et al. Mechanisms of Resistance of Hepatocyte Retinoid X Receptor α-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis* , 2009, Journal of Biological Chemistry.
[147] Per Artursson,et al. Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.
[148] D. Miller,et al. Expression and regulation of the cystic fibrosis gene during rat liver regeneration. , 1992, The American journal of physiology.
[149] S. Kitanaka,et al. Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1beta and HNF-1alpha and the abnormality of HNF-1beta mutants. , 2007, The Journal of endocrinology.
[150] L. Ma,et al. Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. , 1995, Biochemistry.
[151] T. Hasegawa,et al. Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats. , 2006, Life sciences.
[152] T. Hasegawa,et al. Shiga-Like Toxin II Impairs Hepatobiliary Transport of Doxorubicin in Rats by Down-Regulation of Hepatic P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 , 2003, Antimicrobial Agents and Chemotherapy.
[153] G. Kullak-Ublick,et al. Hepatocyte Nuclear Factor (HNF) 1 and HNF4 Mediate Hepatic Multidrug Resistance Protein 2 Up-Regulation during Hepatitis C Virus Gene Expression , 2006, Molecular Pharmacology.
[154] A. Amoroso,et al. Detection of MRP1 mRNA in human tumors and tumor cell lines by in situ RT-PCR. , 2000, Biochemical and biophysical research communications.
[155] M. Lieberman,et al. Altered Gene Expression in the Liver of γ‐Glutamyl Transpeptidase–Deficient Mice , 2000, Hepatology.
[156] M. Fromm,et al. Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver , 2003, Journal of Pharmacology and Experimental Therapeutics.
[157] M. Buchwald,et al. Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. , 1993, Human molecular genetics.
[158] Mei-Hwei Chang,et al. Developmental expression of canalicular transporter genes in human liver. , 2004, Journal of hepatology.
[159] I. Pastan,et al. MRP8, A New Member of ABC Transporter Superfamily, Identified by EST Database Mining and Gene Prediction Program, Is Highly Expressed in Breast Cancer , 2001, Molecular medicine.
[160] J. Wijnholds,et al. MRP6 (ABCC6) Detection in Normal Human Tissues and Tumors , 2002, Laboratory Investigation.
[161] Thomas J. Raub,et al. ALTERED HEPATOBILIARY DISPOSITION OF 5 (AND 6)-CARBOXY-2′,7′-DICHLOROFLUORESCEIN IN Abcg2 (Bcrp1) AND Abcc2 (Mrp2) KNOCKOUT MICE , 2006, Drug Metabolism and Disposition.
[162] M. Beaussier,et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[163] Masashi Kobayashi,et al. Doxorubicin induces expression of multidrug resistance‐associated protein 1 in human small cell lung cancer cell lines by the c‐jun N‐terminal kinase pathway , 2005, International journal of cancer.
[164] P. Olinga,et al. Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[165] S. Ikushiro,et al. Beneficial Effect of Spironolactone Administration on Ethynylestradiol-Induced Cholestasis in the Rat: Involvement of Up-Regulation of Multidrug Resistance-Associated Protein 2 , 2007, Drug Metabolism and Disposition.
[166] H. Glaeser,et al. Variability in human hepatic MRP4 expression: influence of cholestasis and genotype , 2008, The Pharmacogenomics Journal.
[167] Thierry Lavé,et al. Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. , 2002, Biochemical pharmacology.
[168] Y. Shitara,et al. Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury. , 2007, Biological & pharmaceutical bulletin.
[169] G. Hooiveld,et al. Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein. , 1999, Journal of cell science.
[170] F. Simon,et al. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2). , 2009, Toxicology and applied pharmacology.
[171] Houjie Liang,et al. Association of Pregnane X Receptor with Multidrug Resistance-Related Protein 3 and its Role in Human Colon Cancer Chemoresistance , 2009, Journal of Gastrointestinal Surgery.
[172] M. Inoue,et al. Down-Regulation of a Hepatic Transporter Multidrug Resistance-Associated Protein 2 Is Involved in Alteration of Pharmacokinetics of Glycyrrhizin and Its Metabolites in a Rat Model of Chronic Liver Injury , 2008, Drug Metabolism and Disposition.
[173] S. Dymarkowski,et al. Expression of multidrug resistance‐associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[174] H. Hartmannová,et al. Rotor‐type hyperbilirubinaemia has no defect in the canalicular bilirubin export pump , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[175] T. Roskams,et al. Up‐regulation of breast cancer resistance protein expression in hepatoblastoma following chemotherapy: A study in patients and in vitro , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.
[176] N. Hagenbuch,et al. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. , 2001, Journal of hepatology.
[177] C. Klaassen,et al. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. , 2007, Biochimica et biophysica acta.
[178] K. Zatloukal,et al. Hepatobiliary transporter expression in human hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[179] A. Kong,et al. In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice , 2006, Archives of pharmacal research.
[180] Kei-ichi Minami,et al. Change of drug excretory pathway by CCl4-induced liver dysfunction in rat. , 2007, Biochemical pharmacology.
[181] J. Riordan,et al. Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia. , 1992, European journal of biochemistry.
[182] Olivier Fardel,et al. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[183] S. Kojima,et al. Oligonucleotide Microarray Analysis of , 2008 .
[184] M. Kool,et al. A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.
[185] Wen-Chang Chang,et al. Transcriptional regulation of the rat Mrp3 gene promoter by the specificity protein (Sp) family members and CCAAT/enhancer binding proteins. , 2005, Journal of biomedical science.
[186] K. Miyamoto,et al. Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride , 2007, Biopharmaceutics & drug disposition.
[187] I. Arias,et al. Intracellular Trafficking and Regulation of Canalicular ATP-Binding Cassette Transporters , 2000, Seminars in liver disease.
[188] Mi-Sook Kim,et al. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[189] M. Nishimura,et al. Role of soybean oil fat emulsion in the prevention of hepatic xenobiotic transporter mRNA up- and down-regulation induced by overdose of fat-free total parenteral nutrition in infant rats. , 2005, Drug metabolism and pharmacokinetics.
[190] D. Keppler,et al. Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes , 2002, Nature Genetics.
[191] G. Friedlander,et al. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. , 2001, American journal of physiology. Renal physiology.
[192] M. Iwaki,et al. Changes in mRNA expression of ABC and SLC transporters in liver and intestines of the adjuvant-induced arthritis rat. , 2009, Biopharmaceutics & drug disposition.
[193] O. Fardel,et al. Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. , 2002, Biochemical pharmacology.
[194] J. Petrick,et al. Importance of Hepatic Induction of Constitutive Androstane Receptor and Other Transcription Factors That Regulate Xenobiotic Metabolism and Transport , 2007, Drug Metabolism and Disposition.
[195] M. Honda,et al. Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma. , 2008, Journal of hepatology.
[196] J. Bryan,et al. ABCC8 and ABCC9: ABC transporters that regulate K+ channels , 2007, Pflügers Archiv - European Journal of Physiology.
[197] D. Keppler,et al. Induction of cMrp/cMoat gene expression by cisplatin, 2‐ acetylaminofluorene, or cycloheximide in rat hepatocytes , 1997, Hepatology.
[198] Y. Sugiyama,et al. Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors. , 2008, Biological & pharmaceutical bulletin.
[199] J. Boyer,et al. Tumor Necrosis Factor (cid:1) -dependent Up-regulation of Lrh-1 and Mrp3(Abcc3) Reduces Liver Injury in Obstructive Cholestasis* , 2022 .
[200] H. Takikawa,et al. Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury , 2004, Journal of Gastroenterology.
[201] Xingguo Cheng,et al. Regulation of mRNA Expression of Xenobiotic Transporters by the Pregnane X Receptor in Mouse Liver, Kidney, and Intestine , 2006, Drug Metabolism and Disposition.
[202] N. Ballatori,et al. Intracellular glutathione regulates taurocholate transport in HepG2 cells. , 2001, Toxicology and applied pharmacology.
[203] Masaki Kobayashi,et al. Characterization of hepatobiliary organic anion transporters in Long-Evans Cinnamon rats. , 2007, Drug metabolism and pharmacokinetics.
[204] S. Cole,et al. Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions. , 2003, Molecular pharmacology.
[205] M. Kaito,et al. Modulation of organic anion transporting polypeptide 1 and multidrug resistance protein 3 expression in the liver and kidney of Gunn rats. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.
[206] Ulrich Hoffmann,et al. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition , 2006, Expert opinion on drug metabolism & toxicology.
[207] S. Teng,et al. Induction of ABCC3 (MRP3) by pregnane X receptor activators. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[208] M. Karin,et al. Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis , 2007, Drug Metabolism and Disposition.
[209] K. Zatloukal,et al. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[210] V. Vollrath,et al. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. , 1999, The Biochemical journal.
[211] J. Marin,et al. Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis. , 2005, Clinical science.
[212] S. Teng,et al. Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis , 2007, British journal of pharmacology.
[213] N. Van Rooijen,et al. Effect of allyl alcohol on hepatic transporter expression: zonal patterns of expression and role of Kupffer cell function. , 2009, Toxicology and applied pharmacology.
[214] K. Kohno,et al. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. , 1998, Biochemical and biophysical research communications.
[215] G. Decorti,et al. Physiological regulation of P‐glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny , 2003, Development, growth & differentiation.
[216] J. Idle,et al. Role of Pregnane X Receptor in Control of All-Trans Retinoic Acid (ATRA) Metabolism and Its Potential Contribution to ATRA Resistance , 2008, Journal of Pharmacology and Experimental Therapeutics.
[217] J. Boyer,et al. Nuclear receptors RXRα:RARα are repressors for human MRP3 expression , 2007 .
[218] P. Novikoff,et al. MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[219] C. Paulusma,et al. Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content , 2009, Journal of Biological Chemistry.
[220] T. Kamisako,et al. Alteration of the expression of adenosine triphosphate‐binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis , 2005, Journal of gastroenterology and hepatology.
[221] F. Lammert,et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. , 2001, Gastroenterology.
[222] E. Elovic,et al. St. John's Wort , 2001, The Journal of head trauma rehabilitation.
[223] Y. Sugiyama,et al. Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice. , 2006, Biological & pharmaceutical bulletin.
[224] E. Denamur,et al. Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation. , 1997, The Biochemical journal.
[225] M. Perassolo,et al. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. , 2004, Biochemical pharmacology.
[226] D. Rurak,et al. Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[227] P. Annaert,et al. The ontogeny of drug metabolizing enzymes and transporters in the rat. , 2008, Reproductive toxicology.
[228] M. Iwaki,et al. Decreased PXR and CAR inhibit transporter and CYP mRNA Levels in the liver and intestine of mice with collagen-induced arthritis , 2007, Xenobiotica; the fate of foreign compounds in biological systems.
[229] U. Beuers,et al. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. , 2001, Liver.
[230] D. Keppler,et al. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma , 2001, International journal of cancer.
[231] I. Pastan,et al. Decreased accumulation of [14c]carboplatin in human cisplatin‐resistant cells results from reduced energy‐dependent uptake , 2000, Journal of cellular physiology.
[232] H. Takano,et al. The human multidrug resistance protein 2 gene: Functional characterization of the 5′‐flanking region and expression in hepatic cells , 1999, Hepatology.
[233] C. Gartung,et al. Constitutive rat multidrug-resistance protein 2 gene transcription is down-regulated by Y-box protein 1. , 2003, Biochemical and biophysical research communications.
[234] D. Besselsen,et al. Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease , 2007, Drug Metabolism and Disposition.
[235] K. Zatloukal,et al. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. , 2007, The American journal of pathology.
[236] V. Barbu,et al. Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation , 2006, Hepatology.
[237] G. Bartosz,et al. Expression of the human ABCC6 gene is induced by retinoids through the retinoid X receptor. , 2006, Biochemical and biophysical research communications.
[238] Sharmilee P. Sawant,et al. Renal and hepatic transporter expression in type 2 diabetic rats. , 2008, Drug metabolism letters.
[239] Peijin Zhang,et al. Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[240] C. Klaassen,et al. Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[241] E. Jeffery,et al. Sulforaphane and erucin increase MRP1 and MRP2 in human carcinoma cell lines. , 2008, The Journal of nutritional biochemistry.
[242] B. Strandvik,et al. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis , 2000, Hepatology.
[243] T. Kume,et al. Decreased hepatobiliary transport of methotrexate in adjuvant arthritis rats , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[244] J. Peters,et al. Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[245] A. Plomp,et al. ABCC6 and pseudoxanthoma elasticum , 2007, Pflügers Archiv - European Journal of Physiology.
[246] K. Yamada,et al. St. John's Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[247] S. Teng,et al. THE ROLE OF PREGNANE X RECEPTOR IN 2-ACETYLAMINOFLUORENE-MEDIATED INDUCTION OF DRUG TRANSPORT AND -METABOLIZING ENZYMES IN MICE , 2006, Drug Metabolism and Disposition.
[248] N. Itoh,et al. Effects of genetic backgrounds on hyperbilirubinemia in radixin-deficient mice due to different expression levels of Mrp3. , 2007, Biochimica et biophysica acta.
[249] E. Neufeld,et al. Transcriptional Repression of the Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mediated by CCAAT Displacement Protein/cut Homolog, Is Associated with Histone Deacetylation* , 1999, The Journal of Biological Chemistry.
[250] Y. Sugiyama,et al. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function , 2001, American Journal of Gastroenterology.
[251] Peijin Zhang,et al. Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions. , 2003, Molecular pharmacology.
[252] C. Manohar,et al. MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma , 2004, Oncogene.
[253] Katsuya Kobayashi,et al. Expressions of genes encoding drug-metabolizing enzymes are altered after sevoflurane, isoflurane, propofol or dexmedetomidine anesthesia. , 2009, Biomedical research.
[254] T. Roskams,et al. Expression and regulation of ABC transporter genes during liver regeneration , 2018 .
[255] I. Arias,et al. Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[256] P. Borst,et al. MRP2 and 3 in health and disease. , 2006, Cancer letters.
[257] Jianzhu Chen,et al. Influence of PDZK1 on lipoprotein metabolism and atherosclerosis. , 2008, Biochimica et biophysica acta.
[258] P. Neuvonen,et al. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics , 2006, Pharmacogenetics and genomics.
[259] J. Miquel,et al. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function , 2004, Gut.
[260] J. Uitto,et al. Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. , 2006, The Journal of investigative dermatology.
[261] F. Suchy,et al. Differential Developmental Regulation of Rat Liver Canalicular Membrane Transporters Bsep and Mrp2 , 2003, Pediatric Research.
[262] M. Nagino,et al. Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[263] K. Faber,et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[264] L. Homolya,et al. Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1) , 2007, Pflügers Archiv - European Journal of Physiology.
[265] M. Kool,et al. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. , 1999, Cancer research.
[266] D. Moore,et al. Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[267] D. Keppler,et al. Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen , 1998, Archives of Toxicology.
[268] R. Ashfield,et al. Cloning of the Promoters for the β-Cell ATP-Sensitive K-Channel Subunits Kir6.2 and SUR1 , 1998, Diabetes.
[269] P. Meier,et al. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[270] D. Häussinger,et al. Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes. , 1999, The Biochemical journal.
[271] C. Klaassen,et al. Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. , 2006, Life sciences.
[272] T. Kawaguchi,et al. Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis , 2000, Hepatology.
[273] Daisaku Hachimine,et al. The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. , 2007, International journal of oncology.
[274] M. Piquette-Miller,et al. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. , 2001, Canadian journal of physiology and pharmacology.
[275] H. Denk,et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[276] Q. Zhu,et al. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene. , 1996, DNA and cell biology.
[277] M. Müller,et al. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. , 1997, Gastroenterology.
[278] D. Bell,et al. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. , 1998, Cancer research.
[279] Wen Xie,et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. , 2006, The Journal of biological chemistry.
[280] G. Scheffer,et al. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. , 2008, Molecular pharmaceutics.
[281] S. Cole,et al. Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. , 2001, Biochemical and biophysical research communications.
[282] J. Osterreicher,et al. Expression of MRP2 and MDR1 transporters and other hepatic markers in rat and human liver and in WRL 68 cell line. , 2005, Physiological research.
[283] Curtis D. Klaassen,et al. INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER , 2005, Drug Metabolism and Disposition.
[284] F. Di Virgilio,et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. , 2001, Gastroenterology.
[285] F. Gonzalez,et al. Protective Role of Hydroxysteroid Sulfotransferase in Lithocholic Acid-induced Liver Toxicity* , 2003, The Journal of Biological Chemistry.
[286] Mi-Sook Kim,et al. Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[287] F. Lammert,et al. Interleukin-6 regulates hepatic transporters during acute-phase response. , 2004, Biochemical and biophysical research communications.
[288] Michel Eichelbaum,et al. Interindividual variability of canalicular ATP‐binding‐cassette (ABC)–transporter expression in human liver , 2006, Hepatology.
[289] G. Scheffer,et al. Induction of Hepatobiliary Efflux Transporters in Acetaminophen-Induced Acute Liver Failure Cases , 2007, Drug Metabolism and Disposition.
[290] F. Lammert,et al. Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. , 2002, Journal of hepatology.
[291] G. Yen,et al. Induction of hepatic antioxidant enzymes by phenolic acids in rats is accompanied by increased levels of multidrug resistance-associated protein 3 mRNA expression. , 2006, The Journal of nutrition.
[292] P. Meier,et al. Differential expression of bile salt and organic anion transporters in developing rat liver. , 2004, Journal of hepatology.
[293] M. Vore,et al. Translational Regulation of Rat Multidrug Resistance-Associated Protein 2 Expression Is Mediated by Upstream Open Reading Frames in the 5′ Untranslated Region , 2007, Molecular Pharmacology.
[294] D. Häussinger,et al. Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[295] Lorella Pascolo,et al. Gene Expression of ABC Proteins in Hepatocellular Carcinoma, Perineoplastic Tissue, and Liver Diseases , 2002, Molecular medicine.
[296] M. Matsuda,et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.
[297] T. Ishikawa,et al. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. , 2001, Biochemical and biophysical research communications.
[298] Andrei A. Aleksandrov,et al. CFTR (ABCC7) is a hydrolyzable-ligand-gated channel , 2007, Pflügers Archiv - European Journal of Physiology.
[299] P. Meier,et al. Small hepatocytes in culture develop polarized transporter expression and differentiation , 2004, Journal of Cell Science.
[300] J. Boyer,et al. Organ-specific alterations in RARα:RXRα abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis , 2002 .
[301] A. Slitt,et al. Induction of drug metabolism enzymes and transporters by oltipraz in rats , 2008, Journal of biochemical and molecular toxicology.
[302] J. Osterreicher,et al. Zonation of multidrug resistance‐associated protein 2 in rat liver after induction with dexamethasone , 2008, Journal of gastroenterology and hepatology.
[303] Ning Li,et al. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[304] N. Ballatori,et al. Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[305] D. Schrenk,et al. Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. , 1998, Biochemical and biophysical research communications.
[306] C. Deutschman,et al. Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. , 2000, Shock.
[307] J. Boyer,et al. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. , 2009, Gastroenterology.
[308] Hong Sun,et al. Effects of renal failure on drug transport and metabolism. , 2006, Pharmacology & therapeutics.
[309] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[310] A. Unami,et al. Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats. , 2007, Toxicology.
[311] F. Burczynski,et al. Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation , 2005, Journal of cellular physiology.
[312] O. Fardel,et al. Down-Regulation of Organic Anion Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokine Interleukin , 2008 .
[313] M. Ho,et al. Expression of Hepatocyte Transporters and Nuclear Receptors in Children With Early and Late-Stage Biliary Atresia , 2008, Pediatric Research.
[314] A. Rzhetsky,et al. The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.
[315] Balázs Sarkadi,et al. The role of multidrug transporters in drug availability, metabolism and toxicity. , 2003, Toxicology letters.
[316] L. Pulaski,et al. Liver-specific enhancer in ABCC6 promoter-Functional evidence from natural polymorphisms. , 2009, Biochemical and biophysical research communications.
[317] J. Capeau,et al. Role for PKC α and PKC ε in down-regulation of CFTR mRNA in a human epithelial liver cell line , 1998 .
[318] N. Tepsiri,et al. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. , 2005, World journal of gastroenterology.
[319] K. Kuča,et al. The influence of acetylcholinesterase reactivators on selected hepatic functions in rats. , 2008, Basic & clinical pharmacology & toxicology.
[320] B. Zhang,et al. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. , 2005, Journal of experimental & clinical cancer research : CR.
[321] V. Vollrath,et al. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. , 2006, The Biochemical journal.
[322] V. Catania,et al. Hepatic Synthesis and Urinary Elimination of Acetaminophen Glucuronide Are Exacerbated in Bile Duct-Ligated Rats , 2008, Drug Metabolism and Disposition.
[323] K. Mitsumori,et al. Threshold dose of piperonyl butoxide that induces reactive oxygen species-mediated hepatocarcinogenesis in rats , 2009, Archives of Toxicology.
[324] Shufeng Zhou,et al. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. , 2007, Current drug metabolism.
[325] D. Häussinger,et al. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis. , 2003, Archives of biochemistry and biophysics.
[326] C. Klaassen,et al. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[327] Y. Sugiyama,et al. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). , 1998, FEBS letters.
[328] G. Hooiveld,et al. Upregulation of the multidrug resistance genes mrp1 and mdr1b and downregulation of the organic anion transporter mrp2 and bile salt transporter spgp in endotoxemic rat liver , 1998 .
[329] K. Zatloukal,et al. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2006, Gastroenterology.
[330] Michael Dean,et al. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. , 2005, Annual review of genomics and human genetics.
[331] T. Guo,et al. Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. , 2009, Archives of biochemistry and biophysics.
[332] K. Kubo,et al. Induction of Multidrug Resistance-Associated Protein MRP3 in the Liver of Rats Fed with Docosahexaenoic Acid , 2006, Bioscience, biotechnology, and biochemistry.
[333] Balázs Sarkadi,et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). , 2008, Drug discovery today.
[334] Masayuki Yamamoto,et al. Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor‐E2–related factor‐2 transcriptional pathway , 2007, Hepatology.
[335] F. Lammert,et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[336] M. Eichelbaum,et al. Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine , 2006, Clinical pharmacology and therapeutics.
[337] C. Klaassen,et al. Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[338] D. Keppler,et al. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. , 2000, European journal of biochemistry.
[339] Y. Sugiyama,et al. Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.
[340] C. Klaassen,et al. Expression of rat Multidrug Resistance Protein 2 (Mrp2) in male and female rats during normal and pregnenolone-16alpha-carbonitrile (PCN)-induced postnatal ontogeny. , 2002, Toxicology.
[341] D. Moore,et al. trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors , 2006, Molecular Pharmacology.
[342] K. Takagi,et al. Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. , 2008, Biochimica et biophysica acta.
[343] Yuichi Sugiyama,et al. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. , 2003, Biochemical and biophysical research communications.
[344] T. Nishiya,et al. Tienilic acid enhances hyperbilirubinemia in Eisai hyperbilirubinuria rats through hepatic multidrug resistance-associated protein 3 and heme oxygenase-1 induction. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[345] F. Matsuda,et al. Identification of a Novel 974C→G Nonsense Mutation of the MRP2/ABCC2 Gene in a Patient with Dubin-Johnson Syndrome and Analysis of the Effects of Rifampicin and Ursodeoxycholic Acid on Serum Bilirubin and Bile Acids , 2006, The American Journal of Gastroenterology.
[346] C. Klaassen,et al. Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2). , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[347] K. Köhrer,et al. Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[348] R. Evans,et al. Benefit of farnesoid X receptor inhibition in obstructive cholestasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[349] J. Fenyk-Melody,et al. Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR− rats , 2003, Xenobiotica; the fate of foreign compounds in biological systems.
[350] P. D. de Jong,et al. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. , 2003, Survey of ophthalmology.
[351] C. Klaassen,et al. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[352] K. Brouwer,et al. P-glycoprotein Expression, Localization, and Function in Sandwich-Cultured Primary Rat and Human Hepatocytes: Relevance to the Hepatobiliary Disposition of a Model Opioid Peptide , 2004, Pharmaceutical Research.
[353] M. Kool,et al. Tissue Distribution and Induction of Human Multidrug Resistant Protein 3 , 2002, Laboratory Investigation.
[354] P. Borst,et al. Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.
[355] K. Chayama,et al. Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function. , 2001, The Biochemical journal.
[356] F. Leblond,et al. Effects of Chronic Renal Failure on Liver Drug Transporters , 2008, Drug Metabolism and Disposition.
[357] C. Klaassen,et al. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. , 2002, The Journal of pharmacology and experimental therapeutics.
[358] M. Vore,et al. The Role of Protein Synthesis and Degradation in the Post-Transcriptional Regulation of Rat Multidrug Resistance-Associated Protein 2 (Mrp2, Abcc2) , 2005, Molecular Pharmacology.
[359] D. Keppler,et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. , 1997, Gastroenterology.
[360] A. Guillouzo,et al. Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. , 2009, Toxicology and applied pharmacology.
[361] S. Sahlin,et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. , 2005, Gastroenterology.
[362] D. Keppler,et al. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane , 2003, Hepatology.
[363] K. Faber,et al. Multidrug resistance–associated proteins are crucial for the viability of activated rat hepatic stellate cells , 2008, Hepatology.
[364] D. Rees,et al. ABC transporters: the power to change , 2009, Nature Reviews Molecular Cell Biology.
[365] K. Zatloukal,et al. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. , 2003, Journal of hepatology.
[366] M. L. Alvarez,et al. Biliary secretory function in rats chronically intoxicated with aluminum. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[367] M. Negishi,et al. INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS , 2006, Drug Metabolism and Disposition.
[368] M. Piquette-Miller,et al. Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia , 2002, Journal of Pharmacology and Experimental Therapeutics.
[369] M. Kool,et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.
[370] M. Fromm,et al. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. , 2004, Pharmacogenetics.
[371] V. Ling,et al. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.
[372] V. Douet,et al. HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression. , 2006, Biochimica et biophysica acta.
[373] D. Keppler,et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis , 2005, Hepatology.
[374] K. Brouwer,et al. Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity. , 2008, Toxicology and applied pharmacology.
[375] T. Hasegawa,et al. Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters. , 2005, European journal of pharmacology.
[376] K. Pang,et al. Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[377] Y. Sugiyama,et al. Genipin enhances Mrp2 (Abcc2)‐mediated bile formation and organic anion transport in rat liver , 2004, Hepatology.
[378] H. Aburatani,et al. ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. , 2002, Biochemical and biophysical research communications.
[379] C. Garrovo,et al. St John's wort modulation and developmental expression of multidrug transporters in the rat , 2006, Phytotherapy research : PTR.
[380] T. Horie,et al. Canalicular Mrp2 localization is reversibly regulated by the intracellular redox status. , 2008, American journal of physiology. Gastrointestinal and liver physiology.